Seroprevalence of Hepatitis E Virus infection among volunteer blood donors in central province of Iran in 2012

被引:1
作者
Ehteram, Hassan [1 ]
Ramezani, Amitis [2 ]
Eslamifar, Ali [2 ]
Sofian, Masoomeh [4 ]
Banifazl, Mohammad [5 ]
Ghassemi, Shahin [6 ]
Aghakhani, Arezoo [2 ]
Mashayekhi, Parisa [3 ]
机构
[1] Kashan Univ Med Sci, Fac Med, Dept Pathol, Kashan, Iran
[2] Pasteur Inst Iran, Dept Clin Res, Tehran, Iran
[3] Pasteur Inst Iran, Dept Vacinat, 69 Pasture Ave, Tehran 13164, Iran
[4] Arak Univ Med Sci, TB & Pediat Infect Res Ctr, Arak, Iran
[5] Iranian Soc Supporting Patients Infect Dis, Tehran, Iran
[6] Univ Tehran Med Sci, Firoozgar Hosp, Tehran, Iran
关键词
Hepatitis E virus (HEV); Seroprevalence; Blood donor;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background and Objectives: Hepatitis E virus (HEV) is a major public health concern in developing countries. HEV transmission occurs primarily by the fecal-oral route. It has also been reported that blood donors are potentially able to cause transfusion-associated hepatitis E in endemic areas. This study aimed to determine the seroprevalence of HEV infection among volunteer blood donors in Central province of Iran in 2012. Material and Methods: A total of 530 consecutive blood donor samples collected from Blood Transfusion Organization, Central Province of Iran. All samples were tested for the presence of IgG Hepatitis E antibody (anti-HEV) using enzyme linked immunosorbent assay (ELISA). Results: From 530 blood donors, 91.9% were male and 8.1% were female. Overall, anti-HEV was found in 76 of 530 samples (14.3%). There was no significant difference in HEV seropositivity between the subjects regarding gender and area of residence (urban vs. rural). Anti-HEV was distributed among all age groups. Although people aged 31-50 years had the highest prevalence, but there was no statistical difference between the age groups. Conclusion: This study shows a relatively high prevalence of anti-HEV in the blood donors of Central province of Iran. More investigations are needed to assess the potential benefit of adding HEV screening of blood products to the current blood donor selection criteria.
引用
收藏
页码:172 / 176
页数:5
相关论文
共 37 条
[1]  
Abdel Hady S I, 1998, J Egypt Public Health Assoc, V73, P165
[2]  
Acharya Subrat Kumar, 2006, Trop Gastroenterol, V27, P63
[3]  
Aggarwal R, 2010, GLOBAL PREVALENCE HE
[4]   Identification of novel human hepatitis E virus (HEV) isolates and determination of the seroprevalence of HEV in Korea [J].
Ahn, JM ;
Kang, SG ;
Lee, DY ;
Shin, SJ ;
Yoo, HS .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (07) :3042-3048
[5]  
Alavian SM, 2007, HEPAT MON, V7, P119
[6]  
Aminiafshar S., 2004, IRAN J PUBLIC HEALTH, V33, P53
[7]   Hepatitis E virus: can it be transmitted parenterally? [J].
Arankalle, VA ;
Chobe, LP .
JOURNAL OF VIRAL HEPATITIS, 1999, 6 (02) :161-164
[8]  
Arankalle VA, 2000, VOX SANG, V79, P72, DOI 10.1159/000031215
[9]   Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, Southwest Iran [J].
Assarehzadegan, Mohammad Ali ;
Shakerinejad, Ghodratollah ;
Amini, Akram ;
Rezaee, S. A. Rahim .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (04) :387-390
[10]   Hepatitis E virus in Isfahan Province: a population-based study [J].
Ataei, Behrooz ;
Nokhodian, Zary ;
Javadi, Abbas Ali ;
Kassaian, Nazila ;
Shoaei, Parisa ;
Farajzadegan, Ziba ;
Adibi, Peyman .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2009, 13 (01) :67-71